Skip to main content
. 2023 Jul 7;15(3):842–856. doi: 10.3390/neurolint15030053

Figure 1.

Figure 1

Significantly higher levels of CSF sTREM2 in AD compared to MCI (* p = 0.01), and HC (**** p < 0.0001), as well as in the MCI versus HC group (* p = 0.01). AD, Alzheimer’s disease group; CSF, cerebrospinal fluid; HC, healthy control groups, MCI, mild cognitive impairment group; sTREM2, soluble Triggering Receptor Expressed on Myeloid cells 2.